Stryker Corporation (SYK)财务
NYSE · Healthcare · Medical - Devices · 员工56,000人 · CEO Kevin A. Lobo
- 股价
- $291.86 -6.38%
- 市值
- $1120亿
- 企业价值
- $1240亿
- 最近财报
- Q3 '26 2026-10-30提交
- 下次财报
- 2027-02-04 EPS预期 $5.04
营收(TTM)$263亿+7.9% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)21.3%+0.4 百分点 对比去年同期营业利润 $55.9亿
净利润(TTM)$36.2亿+23.1% 对比去年同期税后,含营业外收益
自由现金流(TTM)$45.7亿+12.3% 对比去年同期资本支出 $8.73亿
稀释EPS(TTM)$9.39+23.4% 对比去年同期最近4个季度之和
净现金-$122亿+14.2% 对比去年同期现金 + 短期投资 - 债务
估值与关键数据
- 市值
- $1120亿 EV $1240亿
- 营收
- $263亿 过去12个月
- 营收增速
- +7% FY2026年一致预期
- 净利润率
- 13.8% 净利润 / 营收,TTM
- P/E
- 30.9× 预期 19.6×(FY2026)
- P/S
- 4.3× 股价 / 营收,TTM
- EV / EBITDA
- 18.7× TTM
- 自由现金流
- $45.7亿 过去12个月
- 净利润
- $36.2亿 过去12个月
- 营收预期
- $269亿 FY2026年一致预期
- 盈利
- 2027-02-04 营收预期 $77.5亿
- 股息
- $3.52 每股,过去12个月
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 最近财报(2026-10-29):营收低于预期1.5%,EPS 低于预期0.8%营收$65.2亿,预期$66.2亿(-1.5%);EPS $3.52,预期$3.55(-0.8%)。
- 营收增长平稳:同比7.6%Q3 '26营收$65.2亿,此前四个季度的平均值为8.4%。
- 营业利润率21.3%(TTM),较去年同期+0.4 百分点营收增长7.9%,营业利润增长9.8%。
- 资本支出占营收的3.3%(去年为3.1%)最近4个季度投入$8.73亿(同比+15.0%)。自由现金流$45.7亿,相当于净利润的126.2%。
- 股东回报$24.9亿 = 自由现金流的54.4%回购$11.6亿(去年为$1.81亿),股息$13.3亿,股权激励$1.89亿(TTM)。
- 稀释股数一年内减少0.5%Q3 '26稀释股数3.85亿,一年前为3.87亿。
- 净债务 $122亿现金 + 短期投资 $32.7亿,含租赁债务 $154亿;一年前净债务 $142亿。
- Med Surg And Neurotechnology:营收+9.2%,利润率28.7%(此前为26.1%)Q3 '26增长最快的披露分部:营收$36.6亿,营业利润$10.5亿(来自财报的分部附注)。
上一季度:Q3 '26
截至2026-09-30的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q3 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $65.2亿 | $60.6亿 | +7.6% |
| 毛利率 | 65.2% | 63.6% | +1.6 百分点 |
| 营业利润 | $10.3亿 | $11.4亿 | -8.9% |
| 营业利润率 | 15.9% | 18.7% | -2.9 百分点 |
| 净利润 | $7.53亿 | $8.59亿 | -12.3% |
| 稀释EPS | $1.96 | $2.22 | -11.7% |
| 经营现金流 | $14.6亿 | $15.4亿 | -5.1% |
| 资本支出 | $2.37亿 | $1.87亿 | +26.7% |
| 自由现金流 | $12.2亿 | $13.5亿 | -9.5% |
| R&D | $4.33亿 | $4.1亿 | +5.6% |
| 股权激励费用 | $20万 | $6200万 | -99.7% |
实际 vs 一致预期
2026-10-29| 实际 | 一致预期 | 对比预期 | |
|---|---|---|---|
| 营收 | $65.2亿 | $66.2亿 | -1.5% |
| EPS(一致预期口径) | $3.52 | $3.55 | -0.8% |
来自2026-10-29发布的Q3 '26财报：营收及分析师预期口径的EPS（通常为调整后），可能与上方报表中的EPS不同。
EPS与一致预期
最近8次财报营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度按业务线划分的营收
堆叠,季度| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Orthopaedics | $28.6亿 | +26.7% | 43.8% | $136亿 | – | |
| MedSurg | $36.6亿 | -3.7% | 56.2% | $151亿 | -1.3% |
按地区划分的营收
占总额比例| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| United States | $49.5亿 | – | 75.9% | – | – | |
| Non-US | $15.7亿 | +5.7% | 24.1% | – | – |
分部利润
取自每份10-Q / 10-K分部附注的各披露分部营业利润(多数数据源缺少的利润拆分)。
Q3 '26分部
| 分部 | 营收 | 同比 | 营业利润 | 同比 | 利润率 | 去年同期利润率 | TTM营业利润 |
|---|---|---|---|---|---|---|---|
| Med Surg And Neurotechnology | $36.6亿 | +9.2% | $10.5亿 | +20.4% | 28.7% | 26.1% | $49.7亿 |
| Orthopaedics And Spine | $28.6亿 | +5.7% | – | – | – | – | – |
| Corporate (unallocated) | – | – | – | – | – | – | – |
| Orthopaedics | – | – | $8.91亿 | +1.7% | – | – | $29.4亿 |
各分部营业利润
季度各分部营业利润率
季度第四季度为推算值:10-K披露全年数据,减去10-Q的前三个季度。
利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- $54.5亿
- 资本支出
- -$8.73亿
- 股票回购
- -$11.6亿
- 股息
- -$13.3亿
- 收购
- -$4.91亿
- 债务净发行
- -$15亿
- 股权激励费用
- $1.89亿
- 自由现金流
- $45.7亿
- 股东回报 / FCF
- 54.4%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | 30.9× | 42.6× | 35.9× – 50.6× |
| EV / EBITDA | 18.7× | 25.8× | 23.2× – 30.7× |
| EV / 营收 | 4.7× | 6.1× | 5.6× – 6.5× |
| 股价 / FCF | 24.5× | 37.8× | 31.4× – 45.4× |
| 股价 / 净资产 | 4.8× | 6.2× | 5.6× – 6.8× |
| FCF收益率 | 4.1% | 2.7% | 2.2% – 3.2% |
| 投入资本回报率 | 9.5% | 9.8% | 8.5% – 10.9% |
| 净资产收益率 | 15.6% | 14.7% | 13.4% – 17.0% |
分析师
一致目标价 $355.19 (+21.7%)
区间 $309.00 – $407.00 · 评级 Buy
强烈买入1
买入35
持有16
卖出0
强烈卖出0
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $269亿 | +7.1% | $14.86 | +76.9% | 19.6× | 15 |
| FY2027 | $289亿 | +7.4% | $16.36 | +10.1% | 17.8× | 16 |
| FY2028 | $312亿 | +7.9% | $18.18 | +11.1% | 16.1× | 10 |
| FY2029 | $334亿 | +7.0% | $19.94 | +9.7% | 14.6× | 4 |
| FY2030 | $353亿 | +5.9% | $21.65 | +8.6% | 13.5× | 4 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
Stryker Corporation在近期10-Q / 10-K文件中标记的全部285项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| Accounts Payable, Trade, Current | $16.3亿 | $15亿 | +9.1% | $18亿 | $16.8亿 | +7.1% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $36.9亿 | $36.4亿 | +1.4% | $40.4亿 | $39.9亿 | +1.3% |
| Accounts Receivable, Allowance for Credit Loss, Current | $2.26亿 | $2.23亿 | +1.3% | $2.16亿 | $2.13亿 | +1.4% |
| Accrued Income Taxes, Current | $6500万 | $1.18亿 | -44.9% | $4.18亿 | $5.39亿 | -22.4% |
| Accrued Income Taxes, Noncurrent | $4.13亿 | $4亿 | +3.2% | $4.02亿 | $3.49亿 | +15.2% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $39.4亿 | $36.7亿 | +7.4% | $36.6亿 | $32.4亿 | +13.2% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$5.93亿 | -$7.66亿 | +22.6% | -$6.87亿 | -$2.93亿 | -134.5% |
| Additional Paid in Capital, Common Stock | $27.6亿 | $25.5亿 | +8.3% | $26亿 | $23.6亿 | +10.0% |
| Amortization | – | – | – | $7.32亿 | $6.23亿 | +17.5% |
| Amortization of Intangible Assets | $1.75亿 | $1.89亿 | -7.4% | $7.32亿 | $6.23亿 | +17.5% |
| Asset Impairment Charges | $2.93亿 | $7300万 | +301.4% | $1.7亿 | $9.77亿 | -82.6% |
| Assets | $472亿 | $471亿 | +0.4% | $478亿 | $430亿 | +11.3% |
| Assets for Plan Benefits, Defined Benefit Plan | $5.6亿2025-12-31 | $4.92亿 | +13.8% | $5.6亿 | $4.92亿 | +13.8% |
| Assets, Current | $142亿 | $137亿 | +3.4% | $148亿 | $148亿 | -0.6% |
| Assets, Fair Value Disclosure | $36.8亿 | $36.9亿 | -0.3% | $44.5亿 | $49.8亿 | -10.5% |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset | – | – | – | -$9000万2024-12-31 | -$2.08亿 | +56.7% |
| Cash and Cash Equivalents, at Carrying Value | $32.7亿 | $32.6亿 | +0.5% | $40.1亿 | $36.5亿 | +9.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $32.7亿 | $32.6亿 | +0.5% | $40.1亿 | $36.5亿 | +9.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -$1.2亿 | $8.81亿 | -113.6% | $3.59亿 | $6.81亿 | -47.3% |
| Commercial Paper | $2.5亿 | $0 | – | $0 | $0 | – |
| Common Stock, Capital Shares Reserved for Future Issuance | 3100万2025-12-31 | 1800万 | +72.2% | 3100万 | 1800万 | +72.2% |
| Common Stock, Dividends, Per Share, Declared | $0.88 | $0.84 | +4.8% | $1.572016-12-31 | $1.42 | +10.6% |
| Common Stock, Par or Stated Value Per Share | $0.10 | $0.10 | 0.0% | $0.10 | $0.10 | 0.0% |
| Common Stock, Shares Authorized | 10亿2025-12-31 | 10亿 | 0.0% | 10亿 | 10亿 | 0.0% |
| Common Stock, Value, Outstanding | $3800万 | $3800万 | 0.0% | $3800万 | $3800万 | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $7.36亿 | $8.55亿 | -13.9% | $28.5亿 | $31.2亿 | -8.5% |
| Contract with Customer, Liability | $9.6亿 | $9.39亿 | +2.2% | $10.2亿 | $9.78亿 | +4.7% |
| Contract with Customer, Liability, Revenue Recognized | $7800万 | $1.44亿 | -45.8% | $5.46亿 | $5.53亿 | -1.3% |
| Cost of Revenue | $22.7亿 | $22.1亿 | +3.0% | $90.5亿 | $81.6亿 | +11.0% |
| Current Federal Tax Expense (Benefit) | – | – | – | $4.14亿 | $4.9亿 | -15.5% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $3.13亿 | $2.89亿 | +8.3% |
| Current Income Tax Expense (Benefit) | – | – | – | $8.76亿 | $8.69亿 | +0.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $1.49亿 | $9000万 | +65.6% |
| Debt Instrument, Fair Value Disclosure | $135亿 | $161亿 | -16.0% | $153亿 | $128亿 | +20.1% |
| Debt Securities, Available-for-sale, Current | $0 | $8700万 | -100.0% | $8900万 | $9100万 | -2.2% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $0 | $5000万 | -100.0% | $4100万 | $4700万 | -12.8% |
| Debt, Current | $7.54亿 | $17.5亿 | -56.9% | $10亿 | $14.1亿 | -29.0% |
| Debt, Long-term and Short-term, Combined Amount | $149亿 | $166亿 | -10.0% | $159亿 | $136亿 | +16.6% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $1.86亿 | -$4.62亿 | +140.3% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $1.28亿 | $1.68亿 | -23.8% |
| Deferred Income Tax Assets, Net | $9.01亿 | $13.7亿 | -34.4% | $11亿 | $17.4亿 | -37.0% |
| Deferred Income Tax Expense (Benefit) | $9200万 | $1500万 | +513.3% | $3.92亿 | -$3.7亿 | +205.9% |
| Deferred Income Tax Liabilities, Net | $1.37亿2025-12-31 | $8200万 | +67.1% | $1.37亿 | $8200万 | +67.1% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $7800万 | -$7600万 | +202.6% |
| Deferred Tax Asset, Interest Carryforward | $5600万2025-12-31 | $5200万 | +7.7% | $5600万 | $5200万 | +7.7% |
| Deferred Tax Assets, Gross | $24.7亿2025-12-31 | $30.9亿 | -20.1% | $24.7亿 | $30.9亿 | -20.1% |
| Deferred Tax Assets, Inventory | $5.53亿2025-12-31 | $5.51亿 | +0.4% | $5.53亿 | $5.51亿 | +0.4% |
| Deferred Tax Assets, Net | $9.61亿2025-12-31 | $16.6亿 | -42.1% | $9.61亿 | $16.6亿 | -42.1% |
| Deferred Tax Assets, Net of Valuation Allowance | $23.2亿2025-12-31 | $28.6亿 | -18.9% | $23.2亿 | $28.6亿 | -18.9% |
| Deferred Tax Assets, Operating Loss Carryforwards | $3.15亿2025-12-31 | $4.1亿 | -23.2% | $3.15亿 | $4.1亿 | -23.2% |
| Deferred Tax Assets, Other | $3.52亿2025-12-31 | $3.1亿 | +13.5% | $3.52亿 | $3.1亿 | +13.5% |
| Deferred Tax Assets, State Taxes | $9000万2025-12-31 | $1.67亿 | -46.1% | $9000万 | $1.67亿 | -46.1% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $1.17亿2025-12-31 | $1亿 | +17.0% | $1.17亿 | $1亿 | +17.0% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | $4.01亿2025-12-31 | $2.07亿 | +93.7% | $4.01亿 | $2.07亿 | +93.7% |
| Deferred Tax Assets, Valuation Allowance | $1.48亿2025-12-31 | $2.28亿 | -35.1% | $1.48亿 | $2.28亿 | -35.1% |
| Deferred Tax Liabilities, Gross | $13.6亿2025-12-31 | $12亿 | +13.2% | $13.6亿 | $12亿 | +13.2% |
| Deferred Tax Liabilities, Undistributed Foreign Earnings | $1.39亿2025-12-31 | $6100万 | +127.9% | $1.39亿 | $6100万 | +127.9% |
| Defined Benefit Plan, Accumulated Benefit Obligation | $7.86亿2025-12-31 | $7.48亿 | +5.1% | $7.86亿 | $7.48亿 | +5.1% |
| Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax | $1.09亿2025-12-31 | $1400万 | +678.6% | $1.09亿 | $1400万 | +678.6% |
| Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax | $800万2025-12-31 | $800万 | 0.0% | $800万 | $800万 | 0.0% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标、预期:Financial Modeling Prep。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-K 2024-12-31, 10-Q 2024-09-30
上次刷新未更新（显示旧数据或无数据）：SEC segments。
数据截至 2026-11-01